Content about Warburg Pincus

July 10, 2013

Crossmark, a sales and marketing services company in the consumer goods industry, has named John Compton to its board of directors to serve along with principals of Warburg Pincus, a global private equity firm.

PLANO, Texas — Crossmark, a sales and marketing services company in the consumer goods industry, has named John Compton to its board of directors to serve along with principals of Warburg Pincus, a global private equity firm.

January 15, 2013

Crossmark, a sales and marketing services company in the consumer goods industry, has announced several executive moves, including the appointment of Joe Crafton as CEO. He previously served as company president.

PLANO, Texas — Crossmark, a sales and marketing services company in the consumer goods industry, has announced several executive moves, including the appointment of Joe Crafton as CEO. He previously served as company president.

January 4, 2013

According to a Bloomberg report, Abbott Laboratories, Johnson & Johnson and Sanofi are all potential suitors for Bausch & Lomb's eye care business in a deal that could be valued as high as $10 billion.

NEW YORK — According to a Bloomberg report published Friday morning, Abbott Laboratories, Johnson & Johnson and Sanofi are all potential suitors for Bausch & Lomb's eye care business in a deal that could be valued as high as $10 billion. 

B&L is being shopped by private equity firm Warburg Pincus, which is working with Goldman Sachs Group, Bloomberg reported, and both Abbott and Sanofi have contracted financial advisors as well. 

Other companies who have been invited to bid include Merck and Pfizer. 

December 19, 2012

Consumer goods sales and marketing services company Crossmark will merge with an affiliate of private equity firm Warburg Pincus, Crossmark said Wednesday.

PLANO, Texas — Consumer goods sales and marketing services company Crossmark will merge with an affiliate of private equity firm Warburg Pincus, Crossmark said Wednesday.

The company announced a majority investment by the New York-based firm, saying Crossmark's management owners would maintain a significant equity position and continue to actively lead the company and that the investment will allow it to achieve its growth objectives faster than it could do on its own.'